Better Tolerability Could Make Zealand’s Amylin Drug A Future Obesity Leader
The Danish company’s amylin analog looks like a match for GLP-1 agonists on efficacy, and better on tolerability, and is now moving quickly into Phase II.
The Danish company’s amylin analog looks like a match for GLP-1 agonists on efficacy, and better on tolerability, and is now moving quickly into Phase II.